I have done the dd. This company could soar with any new developement on its drugs. This company has like only one project and if a treatment is formed it could easily pay off all its debt and more. Down around 75% in the last 10 days off of a run for no reason. The chart speaks for itself, the companies potential speaks for itself, great management speaks for itself. Bad short term financials is the only thing holding this back.
Posted by Rocketmist on :
Up 40% so far, all aboard? .065/0.07
Posted by Rocketmist on :
Up 60% so far, all aboard? 0.06/0.08
Posted by cactus33 on :
lol
Posted by Rocketmist on :
its back down to buying range, lots of potential here. I think the reward outweighs the risk.
Posted by Rocketmist on :